Ra Medical Systems Receives NYSE Failure to Satisfy a Continued Listing Rule Notification
Ra Medical Systems Inc., a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announced that on Dec. 4 it received a notice from the New York Stock Exchange that it is not in compliance with a NYSE continued listing requirement for maintaining an
ANGIODYNAMICS SELLS NAMIC fluid management portfolio
AngioDynamics Inc., a provider of innovative, minimally invasive medical devices for oncology, vascular access and peripheral vascular disease, has agreed to sell its NAMIC fluid management portfolio to Medline Industries Inc. for $167.5 million, subject to customary closing conditions including antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The
CHARING CROSS 2019: MEDTRONIC EXPANDS ON KEY AORTIC SOLUTIONS FOR CHALLENGING ANATOMIES
Medtronic plc released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant II/IIs stent graft system in combination with Heli-FX EndoAnchor implants and for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR). The data, which was presented at the Charing Cross
VSA, PRACTICE MANAGEMENT FIRM, OBSERVES 17TH YEAR
Vein Centers of America (VSA) is celebrating its 17th anniversary by offering a complimentary phone consultation with President and CEO David Schmiege. in vein-specific practice management, marketing and revenue cycle management initiatives nationwide. “We have the experience, flexibility, structure and size to implement results quickly and to create the culture
BUTTERFLY IQ WINS CE MARK FOR IPHONE-BASED PORTABLE ULTRASOUND SYSTEM
Connecticut-based Butterfly Network, already selling in the United States, has won the CE Mark and is releasing its single-probe, hand-held, full-body Butterfly iQ portable ultrasound system in Europe. The product consists of a transducer that plugs right into an iPhone or iPad via the Lightning port, and uses a
PK PAPYRUS NOW AVAILABLE IN U.S. FOR CRISIS CORONARY PERFORATIONS
BIOTRONIK is releasing in the United States its PK Papyrus-covered coronary stent, the first new device in many years to be used as an emergency therapy for acute coronary perforations. Because so few of these are expected to be used, but are expected to save many lives, the FDA
VEINPIX ALLOWS PATIENTS TO SEND LEG PIXS QUESTIONS FROM HOME
Realizing the benefits of telemedicine for both medical practices and their patients, Vein Specialists of America (VSA) has created a virtual vein screening platform to give vein practices nationwide the ability to offer virtual screenings to their patients. VeinPIX is a professional way for vein practices to encourage patients to
LEGSTHERAPYAPY.COM OFFERS VENACTIVE COMPRESSION SOCKS
LegsTherapyapy.com is offering VenActive Active Comfort Unisex 15-20 mmHg moderate compression socks designed for work or everyday wear. Moderate compression is encouraged for tired, .achy legs, occupational swelling or evening edema, and leg discomfort from long hours of standing or sitting The Venactive Active Comfort Unisex 15-20 mmHg cushioned compression
VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease
The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes blocked by a blood clot or compressed by anatomical anomalies.
MERZ REGAINS SOLE DISTRIBUTION OF ASCLERA FROM ANGIODYNAMICS
Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins. Also effective April 8, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All HCPs will now be able to purchase Asclera directly